Literature DB >> 23791906

Urinary NGAL levels correlate with differential renal function in patients with ureteropelvic junction obstruction undergoing pyeloplasty.

Nicholas G Cost1, Paul H Noh, Prasad Devarajan, Vesna Ivancic, Pramod P Reddy, Eugene Minevich, Michael Bennett, Christopher Haffner, Marion Schulte, W Robert DeFoor.   

Abstract

PURPOSE: Recent investigations described the use of NGAL, a sensitive biomarker for kidney injury, in the setting of ureteropelvic junction obstruction. We prospectively evaluated urinary NGAL levels in the affected renal pelvis and bladder of children with ureteropelvic junction obstruction undergoing unilateral dismembered pyeloplasty. Our hypothesis was that higher NGAL in the kidney and bladder would correlate with decreased ipsilateral differential function.
MATERIALS AND METHODS: We performed a prospective cohort study in patients treated with unilateral dismembered pyeloplasty from 2010 to 2012. Urine was obtained intraoperatively from the bladder and obstructed renal pelvis. A control population of unaffected children was recruited to provide a voided bladder specimen. Bladder NGAL levels were compared between the study and control populations. We tested our study hypothesis by correlating bladder and renal pelvic NGAL levels with the differential renal function of the affected kidney.
RESULTS: A total of 61 patients with a median age at surgery of 1.62 years (range 0.12 to 18.7) were enrolled in the study. Median bladder NGAL was 18.6 ng/mg (range 1.4-1,650.8) and median renal pelvic NGAL was 26.2 ng/mg (range 1.2-18,034.5, p = 0.004). Median bladder NGAL was significantly higher than in controls (p = 0.004). The correlation of bladder and renal pelvic NGAL with differential renal function was r = -0.359 (p = 0.004) and r = -0.383 (p = 0.002), respectively.
CONCLUSIONS: Bladder NGAL is increased in children with ureteropelvic junction obstruction. Renal pelvic and bladder normalized urinary NGAL levels correlate inversely with the relative function of the affected kidney in cases of unilateral ureteropelvic junction obstruction.
Copyright © 2013 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  LCN2 protein; NGAL; T(1/2); UPJO; biological markers; half-time; human; kidney; neutrophil gelatinase-associated lipocalin; normalized urinary NGAL; uNGAL; ureteral obstruction; ureteropelvic junction obstruction; urinary bladder

Mesh:

Substances:

Year:  2013        PMID: 23791906      PMCID: PMC4106144          DOI: 10.1016/j.juro.2013.05.003

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  23 in total

1.  NGAL in acute kidney injury: from serendipity to utility.

Authors:  Prasad Devarajan
Journal:  Am J Kidney Dis       Date:  2008-09       Impact factor: 8.860

2.  Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery.

Authors:  Jaya Mishra; Catherine Dent; Ridwan Tarabishi; Mark M Mitsnefes; Qing Ma; Caitlin Kelly; Stacey M Ruff; Kamyar Zahedi; Mingyuan Shao; Judy Bean; Kiyoshi Mori; Jonathan Barasch; Prasad Devarajan
Journal:  Lancet       Date:  2005 Apr 2-8       Impact factor: 79.321

3.  Urinary NGAL, cystatin C, β2-microglobulin, and osteopontin significance in hydronephrotic children.

Authors:  Mia Gebauer Madsen; Rikke Nørregaard; Johan Palmfeldt; Lars Henning Olsen; Jørgen Frøkiær; Troels Munch Jørgensen
Journal:  Pediatr Nephrol       Date:  2012-06-19       Impact factor: 3.714

4.  NGAL is an early predictive biomarker of contrast-induced nephropathy in children.

Authors:  Russel Hirsch; Catherine Dent; Holly Pfriem; Janene Allen; Robert H Beekman; Qing Ma; Sudha Dastrala; Michael Bennett; Mark Mitsnefes; Prasad Devarajan
Journal:  Pediatr Nephrol       Date:  2007-09-14       Impact factor: 3.714

Review 5.  Neutrophil gelatinase-associated lipocalin (NGAL): a new marker of kidney disease.

Authors:  Prasad Devarajan
Journal:  Scand J Clin Lab Invest Suppl       Date:  2008

6.  Biomarkers of congenital obstructive nephropathy: past, present and future.

Authors:  Robert L Chevalier
Journal:  J Urol       Date:  2004-09       Impact factor: 7.450

7.  Requirements for accurately diagnosing chronic partial upper urinary tract obstruction in children with hydronephrosis.

Authors:  Stephen A Koff
Journal:  Pediatr Radiol       Date:  2007-12-11

Review 8.  Identification of urinary biomarkers by proteomics in newborns: use in obstructive nephropathy.

Authors:  Stephane Decramer; Petra Zürbig; Stefan Wittke; Harald Mischak; Jean-Loup Bascands; Joost P Schanstra
Journal:  Contrib Nephrol       Date:  2008       Impact factor: 1.580

9.  Non-invasive markers of ureteropelvic junction obstruction.

Authors:  Stephane Decramer; Jean-Loup Bascands; Joost P Schanstra
Journal:  World J Urol       Date:  2007-08-14       Impact factor: 4.226

10.  Serum neutrophil gelatinase-associated lipocalin (NGAL) as a marker of acute kidney injury in critically ill children with septic shock.

Authors:  Derek S Wheeler; Prasad Devarajan; Qing Ma; Kelli Harmon; Marie Monaco; Natalie Cvijanovich; Hector R Wong
Journal:  Crit Care Med       Date:  2008-04       Impact factor: 7.598

View more
  16 in total

1.  Impact of successful pediatric ureteropelvic junction obstruction surgery on urinary HIP/PAP and BD-1 levels.

Authors:  Sudipti Gupta; Lauren Nicassio; Guillermo Yepes Junquera; Ashley R Jackson; Molly Fuchs; Daryl McLeod; Seth Alpert; Venkata R Jayanthi; Daniel DaJusta; Kirk M McHugh; Brian Becknell; Christina B Ching
Journal:  J Pediatr Urol       Date:  2020-03-29       Impact factor: 1.830

2.  The role of urinary NGAL and serum cystatin C in assessing the severity of ureteropelvic junction obstruction in infants.

Authors:  Antigoni Pavlaki; Nikoleta Printza; Evangelia Farmaki; Stella Stabouli; Anna Taparkou; Magdalini Sterpi; John Dotis; Fotios Papachristou
Journal:  Pediatr Nephrol       Date:  2019-10-13       Impact factor: 3.714

Review 3.  Novel biomarkers of acute kidney injury: Evaluation and evidence in urologic surgery.

Authors:  Marianne Schmid; Deepansh Dalela; Rana Tahbaz; Jessica Langetepe; Marco Randazzo; Roland Dahlem; Margit Fisch; Quoc-Dien Trinh; Felix K-H Chun
Journal:  World J Nephrol       Date:  2015-05-06

Review 4.  Prenatal hydronephrosis: postnatal evaluation and management.

Authors:  Vijaya Vemulakonda; Jenny Yiee; Duncan T Wilcox
Journal:  Curr Urol Rep       Date:  2014-08       Impact factor: 3.092

5.  A novel urinary biomarker protein panel to identify children with ureteropelvic junction obstruction - A pilot study.

Authors:  Charan Kumar V Devarakonda; Emily R Shearier; Chaoran Hu; James Grady; Jeremy L Balsbaugh; John H Makari; Fernando A Ferrer; Linda H Shapiro
Journal:  J Pediatr Urol       Date:  2020-06-11       Impact factor: 1.830

6.  Urinary neutrophil glatinase-associated lipocalin level (uNGAL) may predict the severity of congenital hydronephrosis in infants.

Authors:  Rahimpour Amiri; Hiwa Hosseini; Zahra Sanaei; Saba Shamahmoudi; Ghasem Solgi
Journal:  Am J Clin Exp Immunol       Date:  2021-02-15

7.  Role of urinary Neutrophil Gelatinase-Associated Lipocalin (NGAL), Monocyte Chemoattractant Protein-1(MCP-1), and Interleukin-6(IL-6) as biomarkers in pediatric patients with hydronephrosis.

Authors:  Biangchwadaka Suchiang; Manish Pathak; Rahul Saxena; Shailja Sharma; Aliza Mittal; Shubhalaxmi Nayak; Avinash Jadhav; Kirtikumar Rathod; Arvind Sinha
Journal:  Pediatr Surg Int       Date:  2022-09-04       Impact factor: 2.003

8.  Identification of transcripts associated with renal damage due to ureteral obstruction as candidate urinary biomarkers.

Authors:  Bo Wu; Xue Gong; William A Kennedy; James D Brooks
Journal:  Am J Physiol Renal Physiol       Date:  2018-02-28

Review 9.  Prognostic factors and biomarkers of congenital obstructive nephropathy.

Authors:  Robert L Chevalier
Journal:  Pediatr Nephrol       Date:  2015-12-14       Impact factor: 3.714

Review 10.  Immune-Related Urine Biomarkers for the Diagnosis of Lupus Nephritis.

Authors:  María Morell; Francisco Pérez-Cózar; Concepción Marañón
Journal:  Int J Mol Sci       Date:  2021-07-01       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.